Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease

Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease

<p>Abstract</p> <p>Background</p> <p>Glucagon-like peptide-1 (GLP-1) is an incretin hormone that has a wide range of effects on glucose metabolism and cardiovascular function (e.g., improving insulin sensitivity, reduction in appetite, modulation of heart rate, blood pr...

Full description

Bibliographic Details
Main Authors: Masuda Takashi, Aoyama Naoyoshi, Matsunaga Atsuhiko, Takahira Naonobu, Tojo Taiki, Yamaoka-Tojo Minako, Izumi Tohru
Format: Article
Language:English
Published: BMC 2010-05-01
Series:Cardiovascular Diabetology
Online Access:http://www.cardiab.com/content/9/1/17

Internet

http://www.cardiab.com/content/9/1/17

Similar Items